REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · IEX Real-Time Price · USD
21.77
-0.41 (-1.85%)
Mar 28, 2024, 10:58 AM EDT - Market open
REGENXBIO Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 36.55 | 98.98 | 347.24 | 339.76 | 70.84 | 76.61 | 46.88 | 25.07 | 54.12 | 1.12 | Upgrade
|
Short-Term Investments | 240.74 | 267.69 | 112.23 | 137.31 | 226.7 | 244.2 | 114.12 | 64.71 | 60.03 | 0 | Upgrade
|
Cash & Cash Equivalents | 277.29 | 366.67 | 459.47 | 477.07 | 297.54 | 320.81 | 161 | 89.78 | 114.14 | 1.12 | Upgrade
|
Cash Growth | -24.38% | -20.20% | -3.69% | 60.34% | -7.25% | 99.26% | 79.33% | -21.34% | 10082.07% | 0.18% | Upgrade
|
Receivables | 25.49 | 29.59 | 34.7 | 46.27 | 42.3 | 31.6 | 0.47 | 1.03 | 2.14 | 1.88 | Upgrade
|
Other Current Assets | 32.19 | 19.72 | 24.66 | 7.86 | 5.19 | -14.5 | 6.52 | 2.56 | 1.87 | 0.03 | Upgrade
|
Total Current Assets | 334.97 | 415.98 | 518.83 | 531.2 | 345.03 | 337.91 | 168 | 93.37 | 118.15 | 3.03 | Upgrade
|
Property, Plant & Equipment | 192.59 | 206.8 | 192.45 | 120.28 | 39.05 | 28.7 | 13.98 | 9.32 | 0.54 | 0 | Upgrade
|
Long-Term Investments | 38.87 | 200.56 | 391.91 | 46.81 | 103.79 | 150.82 | 15.62 | 69.41 | 102.53 | 0.3 | Upgrade
|
Other Long-Term Assets | 7.54 | 9.93 | 10.72 | 9.88 | 10.04 | 26.38 | 1.09 | 0.63 | 0.17 | 0.16 | Upgrade
|
Total Long-Term Assets | 239 | 417.29 | 595.08 | 176.97 | 152.88 | 205.9 | 30.68 | 79.36 | 103.23 | 0.46 | Upgrade
|
Total Assets | 573.97 | 833.27 | 1,114 | 708.16 | 497.91 | 543.81 | 198.68 | 172.73 | 221.38 | 3.49 | Upgrade
|
Accounts Payable | 22.79 | 27.21 | 11.39 | 10.62 | 6.41 | 4.41 | 4.83 | 1.54 | 1.01 | 5.52 | Upgrade
|
Deferred Revenue | 0.15 | 1.83 | 3.33 | 4.23 | 3.33 | 3.93 | 0 | 0 | 0 | 0 | Upgrade
|
Current Debt | 7.07 | 6 | 1.75 | 2.5 | 2.42 | 0 | 0 | 0 | 0 | 2.4 | Upgrade
|
Other Current Liabilities | 100.27 | 95.4 | 114 | 64.09 | 21.51 | 13.83 | 9.61 | 8.13 | 3.33 | 1.27 | Upgrade
|
Total Current Liabilities | 130.27 | 130.43 | 130.47 | 81.45 | 33.68 | 22.18 | 14.44 | 9.67 | 4.34 | 9.19 | Upgrade
|
Long-Term Debt | 82.22 | 88.8 | 84.93 | 70.15 | 8.87 | 5.85 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Liabilities | 49.73 | 97.84 | 134.21 | 178.81 | 5.16 | 6.94 | 1.21 | 1.33 | 0.23 | 0 | Upgrade
|
Total Long-Term Liabilities | 131.96 | 186.64 | 219.13 | 248.96 | 14.04 | 12.79 | 1.21 | 1.33 | 0.23 | 0 | Upgrade
|
Total Liabilities | 262.23 | 317.07 | 349.61 | 330.41 | 47.71 | 34.97 | 15.65 | 11 | 4.57 | 9.19 | Upgrade
|
Total Debt | 89.29 | 94.8 | 86.68 | 72.65 | 11.3 | 5.85 | 0 | 0 | 0 | 2.4 | Upgrade
|
Debt Growth | -5.81% | 9.37% | 19.31% | 543.23% | 92.94% | - | - | - | - | - | Upgrade
|
Retained Earnings | -705.05 | -441.55 | -161.23 | -289.07 | -177.82 | -83.02 | -187.76 | -114.59 | -51.62 | -28.81 | Upgrade
|
Comprehensive Income | -4.43 | -15.4 | -2.57 | -0.36 | 0.21 | -0.72 | -0.72 | -0.03 | -0.72 | 0 | Upgrade
|
Shareholders' Equity | 311.74 | 516.2 | 764.3 | 377.75 | 450.2 | 508.85 | 183.03 | 161.74 | 216.81 | -18.29 | Upgrade
|
Net Cash / Debt | 188 | 271.87 | 372.79 | 404.42 | 286.25 | 314.96 | 161 | 89.78 | 114.14 | -1.28 | Upgrade
|
Net Cash / Debt Growth | -30.85% | -27.07% | -7.82% | 41.28% | -9.12% | 95.62% | 79.33% | -21.34% | - | - | Upgrade
|
Net Cash Per Share | 4.30 | 6.30 | 8.49 | 10.85 | 7.80 | 8.59 | 5.39 | 3.40 | 12.44 | -0.49 | Upgrade
|
Working Capital | 204.7 | 285.54 | 388.35 | 449.75 | 311.36 | 315.74 | 153.56 | 83.7 | 113.81 | -6.16 | Upgrade
|
Book Value Per Share | 7.13 | 11.96 | 18.01 | 10.13 | 12.27 | 15.22 | 6.13 | 6.12 | 23.64 | -6.92 | Upgrade
|